Cancer Letters
Volume 229, Issue 1 , Pages 49-57 , 8 November 2005

Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-κB-dependent process in human cervical carcinoma cells

  • Eunok Im

      Affiliations

    • Department of Pharmacy and Pusan Cancer Research Center, Pusan National University, Busan 609-735, South Korea
    • ,
  • Sang-Ho Choi

      Affiliations

    • Department of Pharmacy and Pusan Cancer Research Center, Pusan National University, Busan 609-735, South Korea
    • ,
  • Hongsuk Suh

      Affiliations

    • Department of Chemistry and Chemistry Institute for the Functional Materials, Pusan National University, Busan 609-735, South Korea
    • ,
  • Yung Hyun Choi

      Affiliations

    • Department of Biochemistry, College of Oriental Medicine, Dong-Eui University and Research Center of Oriental Medicine, Busan 614-054, South Korea
    • ,
  • Young Hyun Yoo

      Affiliations

    • Department of Anatomy and Cell Biology (BK21 Program), Dong-A University College of Medicine and Medical Science Research Center, Busan 602-714, South Korea
    • ,
  • Nam Deuk Kim

      Affiliations

    • Department of Pharmacy and Pusan Cancer Research Center, Pusan National University, Busan 609-735, South Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 51 5102801; fax: +82 51 5136754.

Received 12 October 2004 ,Revised 24 November 2004 ,Accepted 26 November 2004.

References 

  1. McMillan L, Butcher S, Wallis Y, Neoptolemos JP, Lord JM. Bile acids reduce the apoptosis-inducing effects of sodium butyrate on human colon adenoma (AA/C1) cells: implications for colon carcinogenesis. Biochem. Biophys. Res. Commun. 2000;273:45–49
  2. Narisawa T, Magadia NE, Weinburger JH, Wynder EL. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N′-nitro-N-nitrosoguanidine in rats. J. Natl Cancer Inst. 1974;53:1093–1097
  3. Reddy BS, Watanabe K. Effect of cholesterol metabolites and promoting effect of lithocholic acid in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res. 1979;39:1521–1524
  4. Martinez JD, Stratagoules ED, LaRue JM, Powell AA, Gause PR, Craven MT, et al. Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr. Cancer. 1998;31:111–118
  5. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J. Clin. Invest. 1999;103:137–145
  6. Mahmoud NN, Dannenberg AJ, Bilinski RT, Mestre JR, Chadburn A, Churchill M, et al. Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis. Carcinogenesis. 1999;20:299–303
  7. Sodeman T, Bronk SF, Roberts PJ, Miyoshi H, Gores GJ. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am. J. Physiol. Gastrointest. Liver Physiol. 2000;278:G992–G999
  8. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, et al. Identification of a nuclear receptor for bile acids. Science. 1999;284:1362–1365
  9. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, et al. Bile acids: natural ligands for an orphan nuclear receptor. Science. 1999;284:1365–1368
  10. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell. 1999;3:543–553
  11. Rust C, Karnitz LM, Paya CV, Moscat J, Simari RD, Gores GJ. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J. Biol. Chem. 2000;275:20210–20216
  12. Song CS, Echchgadda I, Baek BS, Ahn SC, Oh T, Roy AK, et al. Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor. J. Biol. Chem. 2001;276:42549–42556
  13. Earnest DL, Holubec H, Wali RK, Jolley CS, Bissonette M, Bhattacharyya AK, et al. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res. 1994;54:5071–5074
  14. Silva RF, Rodrigues CM, Brites D. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. J. Hepatol. 2001;34:402–408
  15. Heuman DM, Bajaj R. Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology. 1994;106:1333–1341
  16. Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 1998;101:2790–2799
  17. Czaja MJ. The future of GI and liver research: editorial perspectives. III. JNK/AP-1 regulation of hepatocyte death. Am. J. Physiol. Gastrointest. Liver Physiol. 2003;284:G875–G879
  18. Glinghammar B, Holmberg K, Rafter J. Effects of colonic lumenal components on AP-1-dependent gene transcription in cultured human colon carcinoma cells. Carcinogenesis. 1999;20:969–976
  19. Brady LM, Beno DWA, Davis BH. Bile acid stimulation of early growth response gene and mitogen-activated protein kinase is protein kinase C-dependent. Biochem. J. 1996;316:756–769
  20. Qiao D, Chen W, Stratagoules ED, Martinez JD. Bile acid-induced activation of activator protein-1 requires both extracellular signal-regulated kinase and protein kinase C signaling. J. Biol. Chem. 2000;275:15090–15098
  21. Higuchi H, Grambihler A, Canbay A, Bronk SF, Gores GJ. Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J. Biol. Chem. 2004;279:51–60
  22. Kim ND, Im EO, Choi YH, Yoo YH. Synthetic bile acids: novel mediators of apoptosis. J. Biochem. Mol. Biol. 2002;35:134–141
  23. Baek JH, Kim J, Kang C, Lee YS, Kim KW. Induction of apoptosis by bile acids in HepG2 human hepatocellular carcinoma cells. Korean J. Physiol. Pharmacol. 1997;1:107–115
  24. Park YH, Kim J, Baek J, Jung E, Kim T, Suh H, et al. Induction of apoptosis in HepG2 human hepatocellular carcinoma cells by a novel derivative of ursodeoxycholic acid (UDCA). Arch. Pharm. Res. 1997;20:29–33
  25. Im EO, Lee S, Suh H, Kim KW, Bae YT, Kim ND. A novel ursodeoxycholic acid derivative induces apoptosis in human MCF-7 breast cancer cells. Pharm. Pharmacol. Commun. 1999;5:293–298
  26. Im EO, Choi YH, Paik KJ, Suh H, Jin Y, Kim KW, et al. Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells. Cancer Lett. 2001;163:83–93
  27. Choi YH, Im EO, Suh H, Jin Y, Lee WH, Yoo YH, et al. Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases. Int. J. Oncol. 2001;18:979–984
  28. Choi YH, Im EO, Suh H, Jin Y, Yoo YH, Kim ND. Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells. Cancer Lett. 2003;199:157–167
  29. Park SE, Choi HJ, Yee SB, Chung HY, Suh H, Choi YH, et al. Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells. Int. J. Oncol. 2004;25:231–236
  30. Kim DK, Lee JR, Kim A, Lee S, Yoo MA, Kim KW, et al. Inhibition of initiation of simian virus 40 DNA replication in vitro by the ursodeoxycholic acid and its derivatives. Cancer Lett. 1999;146:147–153
  31. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248:76–79
  32. Liang XH, Mungal S, Ayscue A, Meissner JD, Wodnicki P, Hockenbery D, et al. Bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53. J. Cell. Biochem. 1995;57:509–521
  33. Tada H, Shiho O, Kuroshima K, Koyama M, Tsukamoto K. An improved colorimetric assay for interleukin 2. J. Immunol. Methods. 1986;93:157–165
  34. Lee S, Cho YS, Shim C, Kim J, Choi J, Oh S, et al. Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-β in the SiHa human cervical carcinoma cell line. Int. J. Cancer. 2001;94:500–507
  35. Liu B, Fang M, Lu Y, Lu Y, Mills GB, Fan Z. Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells. Br. J. Cancer. 2001;85:303–311
  36. Leppä S, Bohmann D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene. 1999;18:6158–6162
  37. Juin P, Hueber AO, Littlewood T, Evan G. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 1999;13:1367–1381
  38. Noguchi K, Kitanaka C, Yamana H, Kokubu A, Mochizuki T, Kuchino Y. Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase. J. Biol. Chem. 1999;274:32580–32587
  39. Salomons GS, Brady HJ, Verwijs-Janssen M, Van Den Berg JD, Hart AA, Van Den Berg H, et al. The Baxα:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia. Int. J. Cancer. 1997;71:959–965
  40. Luo Y, Hattori A, Munoz J, Qin Z, Roth GS. Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-κB in rats. Mol. Pharmacol. 1999;56:254–264
  41. Johnson PF, McKnight SL. Eukaryotic transcriptional regulatory proteins. Annu. Rev. Biochem. 1989;58:799–839
  42. Smeal T, Binetruy B, Mercola DA, Birrer M, Karin M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature. 1991;354:494–496
  43. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270:1326–1331
  44. Grambihler A, Higuchi H, Bronk SF, Gores GJ. cFLIP-L inhibits p38 MAPK activation. An additional anti-apoptotic mechanism in bile acid-mediated apoptosis. J. Biol. Chem. 2003;278:26831–26837
  45. Reinehr R, Häussinger D. Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95. Gastroenterology. 2004;126:249–262
  46. Ichijo H. From receptors to stress-activated MAP kinases. Oncogene. 1999;18:6087–6093
  47. Hill CS, Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell. 1995;80:199–211
  48. Kaltschmidt B, Kaltschmidt C, Hofmann TG, Hehner SP, Dröge W, Schmitz ML. The pro- or anti-apoptotic function of NF-κB is determined by the nature of the apoptotic stimulus. Eur. J. Biochem. 2000;267:3828–3835
  49. Shishodia S, Aggarwal BB. Nuclear factor-κB: a friend or a foe in cancer?. Biochem. Pharmacol. 2004;68:1071–1080
  50. Higuchi H, Gores GJ. Bile acid regulation of hepatic physiology. IV. Bile acids and death receptors. Am. J. Physiol. Gastrointest. Liver Physiol. 2003;284:G734–G738
  51. Di Cristofano A, Kotsi P, Peng YF, Cordon-Cardo C, Elkon KB, Pandolfi PP. Impaired Fas response and autoimmunity in Pten+/- mice. Science. 1999;285:2122–2125

PII: S0304-3835(04)00968-1

doi: 10.1016/j.canlet.2004.11.055

Cancer Letters
Volume 229, Issue 1 , Pages 49-57 , 8 November 2005

Article Tools

* Image Usage & Resolution